Clinical Trial Update: Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission [Phase 2]

View source ↗

Summary

Phase 2 study evaluating dendritic cell vaccination as an efficacy treatment in patients with acute myeloid leukemia in remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Dendritic Cell Vaccination (dendritic cell vaccine)

Snippet

Sponsor: Zwi Berneman | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING